Multiple sclerosis (MS) is a chronic neurological disease that manifests with clinical and subclinical attacks of central nervous system demyelination. Women are at least twice as likely as men to develop MS, with a mean age of onset of 30 years. Pregnancy has no adverse long-term effect on disease progression, but it is associated with a higher relapse rate in the immediate postpartum period. Pregnancy can worsen pre-existing urinary/bowel dysfunction and motor problems. MS is not associated with significant obstetric or neonatal complications. Learning objectivesTo understand how to manage pregnant women with MS in the multidisciplinary setting.To understand the importance of pre-pregnancy counselling for women with MS who are on disease-modifying drugs. To understand the implications of pregnancy on MS symptoms and their management. To be aware of the benefits of breastfeeding and the safety of disease-modifying drugs and lactation. Ethical issuesIn the absence of clear guidelines, should women ever be advised to avoid pregnancy? Should women be offered in vitro fertilisation treatment, which is known to increase disease relapse?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.